Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Polymerase Chain Reaction

  • Home
  •  
  • Polymerase Chain Reaction



  • Most Read
  • Latest Comments
  • Genetic Signatures receives TGA nod for updated respiratory kit in time for influenza season
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Genetic Signatures receives TGA nod for updated respiratory kit in time for influenza season
    • News

    AV uptake leads Audinate to push European expansion through recruiting drive
    Public
  • Genetic Signatures receives TGA nod for updated respiratory kit in time for influenza season
    • Opinion

    What the SportsBet-BetEasy merger means for TabCorp and punters
    Public
  • Genetic Signatures receives TGA nod for updated respiratory kit in time for influenza season
    • News

    Why this Tasmanian whisky brand had a record sales quarter
    Public
  • Genetic Signatures receives TGA nod for updated respiratory kit in time for influenza season
    Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • Genetic Signatures halts development of US respiratory product due to competition
    Genetic Signatures halts development of US respiratory product due to competition
    • News

  • Genetic Signatures receives TGA nod for updated respiratory kit in time for influenza season
    Genetic Signatures receives TGA nod for updated respiratory kit in time for influenza season
    • News

  • Genetic Signatures lodges FDA application for rapid test kit to detect intestinal parasites
    Genetic Signatures lodges FDA application for rapid test kit to detect intestinal parasites
    • News

  • Genetic Signatures’ testing kits approved in EU to address worrying STI numbers
    Genetic Signatures’ testing kits approved in EU to address worrying STI numbers
    • News

  • The ASX biotechs surfing the COVID-19 story
    The ASX biotechs surfing the COVID-19 story
    • Opinion

  • Genetic Signatures receives TGA nod for updated respiratory kit in time for influenza season
    • News

    Genetic Signatures receives TGA nod for updated respiratory kit in time for influenza season

    Flu season is around the corner, typically affecting us between May and September. Just in time for that, Australian global molecular diagnostics company Genetic Signatures (ASX: GSS) is gearing up to launch its modified respiratory kit in the country. The Company reported that the Therapeutic Goods Administration (TGA) has completed the review of its redesigned

    Read More
    Public

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.